Parkside Financial Bank & Trust’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$31.3K Buy
995
+538
+118% +$17K ﹤0.01% 1150
2025
Q4
$13.5K Buy
457
+431
+1,658% +$12K ﹤0.01% 1449
2025
Q3
$657 Buy
26
+15
+136% +$366 ﹤0.01% 2437
2025
Q2
$264 Buy
+11
New +$255 ﹤0.01% 2653
2024
Q4
Sell
-47
Closed -$1.17K 2182
2024
Q3
$1.17K Hold
47
﹤0.01% 1682
2024
Q2
$1.39K Hold
47
﹤0.01% 1606
2024
Q1
$1.42K Hold
47
﹤0.01% 1561
2023
Q4
$1.34K Buy
+47
New +$1.38K ﹤0.01% 1560

Other funds holding RTO

Parkside Financial Bank & Trust's RTO Position: Q1 2026 in Review

Parkside Financial Bank & Trust increased its Rentokil (RTO) stake by 118% in Q1 2026, buying an estimated $17K and bringing the position to 995 shares worth $31.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1150.

Parkside Financial Bank & Trust first reported a position in RTO in Q4 2023 and has held it in 8 quarters since. 282 funds tracked by Wall St. Rank hold RTO as of Q1 2026.

  • Parkside Financial Bank & Trust held 995 shares of Rentokil worth $31.3K as of Q1 2026.
  • Parkside Financial Bank & Trust bought 538 Rentokil shares in Q1 2026, an estimated $17K.
  • Rentokil made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #1150 holding.
  • Parkside Financial Bank & Trust first reported a position in Rentokil in Q4 2023 and has held it in 8 quarters since.
  • 282 funds tracked by Wall St. Rank held Rentokil as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.